TARO-TESTOSTERONE CYPIONATE INJECTION
TARO-TESTOSTERONE CYPIONATE INJECTION
Approved
DIN Number
02496003
Drug Class
Human
Market Date
Oct 20, 2020
Company
HC
Taro Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02496003
AIG Number0106401001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification68:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TESTOSTERONE CYPIONATEActive
Strength: 100 MG / ML
Monograph: TESTOSTERONE CYPIONATE